1. AVEMAR
    1. Product information
      1. Review 1
        The product and its registration status
      2. Review 2
        The Approved Avemar label
      3. Product name
      4. Composition
      5. Indications
      6. Mode of action
      7. Preclinical anti-cancer effects
      8. Clinical efficacy
      9. Safety profile
      10. Known interactions with other drugs
      11. Warning
      12. Preparation, dosage and administration
    2. Mode of action
      1. Review 1
        Immunological effects
      2. Review 2
        The effects of avemar on the metabolism of cancer cells
      3. Review 3
        The effects of avemar on the escape/survival strategies of cancer cells
      4. Immunmodulatory effect
      5. Induction of apoptosis
      6. Effect on glucose/nucleic acid metabolism
      7. Selective inhibition of MHC-I (main histocompatibility-I) antigen expression on cell surface
      8. Increasing the production of TNF-Alpha (tumor necrosis factor Alpha)
      9. Increase in the ICAM-I (intracellular adhesion molecule)( CD 45) level
    3. Preclinical results
      1. Review
        Conclusions drawn from experimental studies
      2. Inhibition of metastases in mice
      3. The combination of Avemar with cytostatics
      4. Prevention
      5. Increase in haemopoiesis
    4. Clinical oncological effects
      1. Review
        The supportive effects ofavemar in clinical care
      2. Increasing the likelihood of survival
        Focusing on colorectal carcinoma itself.
      3. Inhibiting progression
        Focusing on the melanoma of the skin itself.
        Focusing on squamous cell cancer of the oral cavity itself.
      4. Improving the quality of life
        Focusing on breast cancer itself.
        Focusing on lung cancer itself.
        Focusing on head and neck cancers itself.
      5. Febrile neutropenia
        Focusing on malignant tumors in childhood itself.
    5. Frequently asked questions
    6. References
  2. CANCER RESEARCH AND ONCOLOGY
    1. Review
      Survey of malignant tumours
    2. Solid tumours
      1. Colorectal cancer
      2. Melanoma of the skin
      3. Squamous cell cancer of the oral cavity
      4. Breast cancer
      5. Lung cancer
      6. Head and neck cancers
      7. Adenocarcinoma of the pancreas
    3. Leukemia
    4. Malignant tumours in childhood
  3. IMMUNOLOGY & AUTOIMMUNE DISEASES
    1. Review
      Survey of autoimmune diseases
    2. Rheumatoid arthritis
    3. SLE
  4. SCIENCE
    1. Animated trailer
    2. Conference highlights
  5. LOUNGE
    1. Take the Avemar quiz
    2. Request more information
    3. Subscribe to the newsletter
    4. Send this page to your colleague
  6. LIBRARY
    1. Scientific publications
    2. Media
    3. History
    4. Who Is Who?
    5. Press releases
    6. Campaign
    7. Downloads
  7. AVEMAR SHOP
  8. AVEMAR WORLDWIDE
Contacts  |  Legal notice  |  Bookmark this page  |  Interactive site map  |  Credits